APOE and Alzheimer disease: Downregulated DEGs in WM and vasculature in APOE E4+ carriers were also enriched for myelination-related GO terms, which may reflect early changes leading to reduced or altered myelination, which has been observed in the WM of AD patients, particularly in the ERC15.